Robert I Blum sold $314K of Cytokinetics (CYTK)

Executed Oct 30 2025, disclosed Oct 30 2025, the same day.

Value, as filed

$314K

5,000 sh × $62.86

Executed

Oct 30 2025

the trade date, as filed

Disclosed

Oct 30 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Robert I Blum President & CEO profile →

Robert I Blum (President & CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $7.3M of CYTK (105,426 sh across 2 lots, as filed), executed Sep 14.

The name

CYTK

Cytokinetics, Incorporated CYTK · Healthcare · 120 filings in 24 months ticker →

Healthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Robert I Blum in CYTK

CYTKSALE Cytokinetics, Incorporated $7.3M
105,426 sh across 2 lots
Exec Sep 14
Filed Sep 15 · 5:20 PM ET CYTKSALE Cytokinetics, Incorporated $527K
7,500 sh × $70.24
Exec Aug 31
Filed Aug 31 · 4:55 PM ET CYTKSALE Cytokinetics, Incorporated $576K
7,500 sh × $76.76
Exec Aug 10
Filed Aug 10 · 5:11 PM ET CYTKSALE Cytokinetics, Incorporated $607K
7,500 sh × $80.87
Exec Jul 27
Filed Jul 27 · 4:33 PM ET CYTKSALE Cytokinetics, Incorporated $614K
7,490 sh × $82.02
Exec Jul 13
Filed Jul 14 · 3:34 PM ET CYTKSALE Cytokinetics, Incorporated $637K
7,500 sh × $84.92
Exec Jul 1
Filed Jul 2 · 5:20 PM ET CYTKSALE Cytokinetics, Incorporated $528K
7,500 sh × $70.46
Exec Jun 15
Filed Jun 15 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $579K
7,500 sh × $77.21
Exec May 27
Filed May 28 · 5:30 PM ET